The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kills Human Leukemia Cells via Down-Regulation of Mcl-1 through a Transcriptional Mechanism
Molecular Pharmacology (2006) - Comments
pubmed: 16672643  doi: 10.1124/mol.106.024505  issn: 0026-895x  issn: 1521-0111 

Ning Gao, Lora Kramer, Mohamed Rahmani, Paul Dent, Steven Grant